Stock MRHL MERCHAVIA HOLDINGS AND INVESTMENTS LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Merchavia Holdings and Investments Ltd

Equities

MRHL

IL0002570146

Biotechnology & Medical Research

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 07:54:31 30/05/2024 pm IST 		5-day change 1st Jan Change
79.2 ILa -1.61% Intraday chart for Merchavia Holdings and Investments Ltd -9.59% -16.19%
31/03 Merchavia Holdings and Investments Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
06/03 E.F.A. Engineering For All Ltd announced that it has received $3 million in funding from Merchavia Holdings and Investments Ltd CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 21.39 20.64 55.5 57.32 27.02 15.87
Enterprise Value (EV) 1 16.62 17.82 46.44 49.89 22.77 13.68
P/E ratio 34.2 x 4.66 x 17.6 x 9.97 x -7.9 x -0.98 x
Yield - - - - - -
Capitalization / Revenue 8.39 x 2.83 x 7.47 x 5.4 x 6.49 x 8.59 x
EV / Revenue 6.52 x 2.44 x 6.25 x 4.7 x 5.47 x 7.4 x
EV / EBITDA 13.1 x 3.67 x 10.4 x 6.97 x 15.5 x -65.4 x
EV / FCF 7.19 x 5.12 x 7.72 x 8.64 x 13.6 x 25.1 x
FCF Yield 13.9% 19.5% 13% 11.6% 7.33% 3.98%
Price to Book 0.91 x 0.65 x 1.49 x 1.2 x 0.62 x 0.55 x
Nbr of stocks (in thousands) 12,511 13,232 14,800 16,425 16,425 16,799
Reference price 2 1.710 1.560 3.750 3.490 1.645 0.9450
Announcement Date 28/03/19 26/04/20 31/03/21 30/03/22 29/03/23 31/03/24
1ILS in Million2ILS
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2.549 7.304 7.426 10.61 4.161 1.848
EBITDA 1 1.264 4.856 4.466 7.155 1.469 -0.209
EBIT 1 1.256 4.852 4.46 7.147 1.461 -0.221
Operating Margin 49.27% 66.43% 60.06% 67.37% 35.11% -11.96%
Earnings before Tax (EBT) 1 0.876 4.553 2.988 5.852 -3.607 -16.23
Net income 1 0.876 4.553 2.988 5.852 -3.607 -16.23
Net margin 34.37% 62.34% 40.24% 55.16% -86.69% -878.3%
EPS 2 0.0500 0.3347 0.2125 0.3500 -0.2083 -0.9600
Free Cash Flow 1 2.312 3.478 6.016 5.777 1.67 0.5449
FCF margin 90.72% 47.62% 81.02% 54.45% 40.14% 29.48%
FCF Conversion (EBITDA) 182.94% 71.62% 134.72% 80.74% 113.69% -
FCF Conversion (Net income) 263.97% 76.39% 201.36% 98.72% - -
Dividend per Share - - - - - -
Announcement Date 28/03/19 26/04/20 31/03/21 30/03/22 29/03/23 31/03/24
1ILS in Million2ILS
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 4.77 2.83 9.06 7.43 4.25 2.2
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 2.31 3.48 6.02 5.78 1.67 0.54
ROE (net income / shareholders' equity) 4.09% 17% 8.89% 13.8% -7.78% -44%
ROA (Net income/ Total Assets) 3.52% 11% 8.04% 10.3% 1.93% -0.36%
Assets 1 24.87 41.42 37.17 57.08 -186.6 4,459
Book Value Per Share 2 1.880 2.400 2.510 2.910 2.670 1.720
Cash Flow per Share 2 0.3800 0.2300 0.6100 0.4500 0.2400 0.1300
Capex 1 0 - 0.02 - 0.01 0.02
Capex / Sales 0.12% - 0.31% - 0.22% 0.81%
Announcement Date 28/03/19 26/04/20 31/03/21 30/03/22 29/03/23 31/03/24
1ILS in Million2ILS
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MERCHAVIA HOLDINGS AND INVESTMENTS LTD Stock Merchavia Holdings and Investments Ltd
-16.19% 35.9L
MODERNA, INC. Stock Moderna, Inc.
+43.36% 5.81TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.31% 4.05TCr
LONZA GROUP AG Stock Lonza Group AG
+37.52% 3.9TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.75% 2.67TCr
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 2.66TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.45% 1.9TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.04% 1.22TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.12% 1.2TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.04% 1.19TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MRHL Stock
  4. Financials Merchavia Holdings and Investments Ltd